AbstractHIGHLIGHTS
This report:
- Describes various imaging reagent types including optical probes and dyes,
imaging nanomaterials, supermolecules, contrast agents and radiopharmaceuticals
- Provides market forecasts to determine the global market and future demand
growth for biologic imaging reagents over a 5-year period, from 2008 to 2013
- Evaluates future growth opportunities in imaging reagents for life science
companies
- Provides a comprehensive discussion of where state-of-the-art is in
biologic imaging reagents and forecasts the future market potential for key
market segments
- Includes company profiles and industry alliances.
SCOPE OF REPORT
The study scope includes the biologic imaging reagents that are commercial or
likely to be commercialized within the next five years. Fluorescent probes and
dyes, imaging nanomaterials (including quantum dots and other nanoparticles),
fluorescent proteins; supermolecules; contrast reagents for MRI, x-ray and
ultrasound, and imaging radiopharmaceuticals are studied. Both the in-vivo and
in-vitro market segments are included. Each technology is analyzed to
determine its market status, impact on future market segments, and forecasted
growth from 2008 through 2013. Technology status and market driving forces are
also discussed.
BCC examines imaging reagent producers and the industry structure in
specialized segments of the industry. We also review industry alliances and
acquisitions, and the use of biologic imaging reagents in key diagnostics and
R&D tools platforms including microarrays, lab-on-a-chip devices, DNA
sequencing, PCR and cellular analysis. The markets for novel biologic
imaging reagent applications, including targeted multifunctional and hybrid
therapeutic reagents are analyzed, and the main companies in these fields are
highlighted.
METHODOLOGY
BCC surveyed key users and producers in each of the end user market segments
and technology fields that will be commercially important during the next five
years. Discussions with industry thought leaders, as well as secondary
market research was performed.
Based on our analysis, we project the future applications of biologic imaging
reagents in the major end user market segments and by technology type, and
forecast sales revenues for 2008 through 2013.
INFORMATION SOURCES
BCC surveyed academic, government and industrial institutions to obtain data
for this study. Included were life science research tools, pharmaceutical,
diagnostic, biotechnology and nanotechnology firms, and leading life science
research institutions. We also spoke with leading industry thought leaders. In
addition, we compiled data from secondary sources including industry, trade,
and government.
| 
View Cart
